| Titre |
Auteur(s) |
Revue |
Année |
Volume |
Page |
PMID |
| First-line immune-checkpoint inhibitor plus chemotherapy versus chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis |
Thierry Landre , Kader Chouahnia, Gaëtan Des Guetz, Boris Duchemann, Jean-Baptiste Assié and Christos Chouaïd |
Therapeutic Advances in Medical Oncology |
Novembre 2020 |
12 |
1758835920977140 |
33343721 |
| Immune Checkpoint Inhibitors for Patients Aged ≥ 75 Years with Advanced Cancer in First- and Second-Line Settings: A Meta-Analysis. |
Landre, T ; Des Guetz, G ; Chouahnia, K ; Fossey-Diaz, V ; Culine, S |
Drugs Aging |
2020 |
37 |
747-754 |
32681403 |
| First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation. |
Landre, T ; Des Guetz, G ; Chouahnia, K ; Duchemann, B ; Assié, JB ; Chouaid, C |
J Cancer Res Clin Oncol |
2020 |
146 |
3333-3339 |
32632581 |
| Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLD. |
Aparicio, T ; Darut-Jouve, A ; Khemissa Akouz, F ; Montérymard, C ; Artru, P ; Cany, L & al |
J Geriatr Oncol |
2020 |
11 |
1255-1262 |
32334940 |
| Withholding the Introduction of Anti-Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild-Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study). |
Palmieri, LJ ; Mineur, L ; Tougeron, D ; Rousseau, B ; Granger, V ; Gornet, JM & al |
Oncologist |
2020 |
25 |
e266-e275 |
32043796 |
| Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study. |
Tougeron, D ; Sueur, B ; Zaanan, A ; de la Fouchardiére, C ; Sefrioui, D ; Lecomte, T & al |
Int J Cancer |
2020 |
147 |
285-296 |
31970760 |
| First-line PD-1/PD-L1 inhibitor plus chemotherapy vs chemotherapy alone for negative or < 1% PD-L1-expressing metastatic non-small-cell lung cancers. |
Landre, T ; Des Guetz, G ; Chouahnia, K ; Taleb, C ; Vergnenègre, A ; Chouaïd, C |
J Cancer Res Clin Oncol |
2020 |
146 |
441-448 |
31686247 |